BusinessConformis to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 2, 2018By Nasdaq OMXApr 12, 2018, 8:05 PM UTC
BusinessFour-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CRBy Nasdaq OMXMar 7, 2018, 1:02 PM UTC
BusinessLeader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee ImplantsBy Nasdaq OMXOct 16, 2017, 12:00 PM UTC
BusinessConforMIS Acquires Machining and Polishing Assets from Broad Peak ManufacturingBy Nasdaq OMXAug 9, 2017, 11:00 AM UTC
BusinessConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 GuidanceBy Nasdaq OMXAug 3, 2017, 8:05 PM UTC
BusinessConforMIS Names Dan Krupp Senior Vice President U.S. SalesBy Nasdaq OMXJul 11, 2017, 8:10 PM UTC
BusinessConforMIS Announces FDA 510(k) Clearance for iTotal Hip SystemBy Nasdaq OMXJun 20, 2017, 12:01 PM UTC
BusinessConforMIS Announces the Publication of Clinical and Economic Study Comparing Customized Total Knee Replacement Implants to Off-the-Shelf Total Knee Replacement ImplantsBy Nasdaq OMXJun 13, 2017, 12:00 PM UTC